Dr Lukasz Kedzierski completed his PhD at Monash University, where he tested efficacy of a novel malaria vaccine antigen in a murine model of infection. Subsequently, he moved to WEHI where he worked on the protozoan parasite Leishmania. His projects involved investigation of host-parasite interactions, drug discovery and anti-parasite immunity. He then shifted his focus to investigate the role of suppressors of cytokine signalling during viral infection. In 2017, Lukasz moved to the Department of Microbiology and Immunology at the University of Melbourne as a Senior Research Fellow. Current projects involve understanding viral persistence in the CNS, immune mechanisms in viral co-infections and mechanisms of vaccine failure.
Lukasz was awarded an NHMRC Postdoctoral Fellowship while at WEHI. He was/is a CI on NHMRC and ARC grants. He was invited (sole representative from Australia) to the 1st and 2nd International Symposium On Leishmaniasis Vaccines (Brazil), and co-authored a report with recommendations to the Brazilian Ministry of Health, published as a policy platform in PLoS NTD. His work on SOCS proteins was featured in daily newspapers (Herald Sun, Advertiser, Courier Mail) and online (Science Daily, Medical News Today) and his paper on SOCS4 has been selected as one of the top 10 published in ICB 2023. He published over 80 research articles including Immunity, Nature Immunology, Nature Communications, Cell Reports Medicine.
Professor Katherine Kedzierska’s team researches immunity to viral infections, especially the newly emerged SARS-CoV-2 and influenza viruses. Her work spans basic research from mouse experiments to human immunity through to clinical settings, with particular focus on understanding universal CD8+ T cell immunity to respiratory viruses. Her studies aim to identify key correlates of severe and fatal respiratory disease in high-risk groups including children, the elderly, Australian First Nations people, pregnant women and patients with co-morbidities.
Full University of Melbourne profile